277 related articles for article (PubMed ID: 1692081)
1. In vitro and in vivo modification of Neisseria gonorrhoeae lipooligosaccharide epitope structure by sialylation.
Mandrell RE; Lesse AJ; Sugai JV; Shero M; Griffiss JM; Cole JA; Parsons NJ; Smith H; Morse SA; Apicella MA
J Exp Med; 1990 May; 171(5):1649-64. PubMed ID: 1692081
[TBL] [Abstract][Full Text] [Related]
2. Anaerobic growth and cytidine 5'-monophospho-N-acetylneuraminic acid act synergistically to induce high-level serum resistance in Neisseria gonorrhoeae.
Frangipane JV; Rest RF
Infect Immun; 1993 May; 61(5):1657-66. PubMed ID: 8478054
[TBL] [Abstract][Full Text] [Related]
3. The surface structure seen on gonococci after treatment with CMP-NANA is due to sialylation of surface lipopolysaccharide previously described as a 'capsule'.
Fox AJ; Curry A; Jones DM; Demarco de Hormaeche R; Parsons NJ; Cole JA; Smith H
Microb Pathog; 1991 Sep; 11(3):199-210. PubMed ID: 1724790
[TBL] [Abstract][Full Text] [Related]
4. α-2,3-sialyltransferase expression level impacts the kinetics of lipooligosaccharide sialylation, complement resistance, and the ability of Neisseria gonorrhoeae to colonize the murine genital tract.
Lewis LA; Gulati S; Burrowes E; Zheng B; Ram S; Rice PA
mBio; 2015 Feb; 6(1):. PubMed ID: 25650401
[TBL] [Abstract][Full Text] [Related]
5. Sialylation of lipopolysaccharide and loss of absorption of bactericidal antibody during conversion of gonococci to serum resistance by cytidine 5'-monophospho-N-acetyl neuraminic acid.
Parsons NJ; Andrade JR; Patel PV; Cole JA; Smith H
Microb Pathog; 1989 Jul; 7(1):63-72. PubMed ID: 2509853
[TBL] [Abstract][Full Text] [Related]
6. Effect of sialylation of lipopolysaccharide of Neisseria gonorrhoeae on recognition and complement-mediated killing by monoclonal antibodies directed against different outer-membrane antigens.
de la Paz H; Cooke SJ; Heckels JE
Microbiology (Reading); 1995 Apr; 141 ( Pt 4)():913-20. PubMed ID: 7539687
[TBL] [Abstract][Full Text] [Related]
7. Lipo-oligosaccharides (LOS) of mucosal pathogens: molecular mimicry and host-modification of LOS.
Mandrell RE; Apicella MA
Immunobiology; 1993 Apr; 187(3-5):382-402. PubMed ID: 8330904
[TBL] [Abstract][Full Text] [Related]
8. A high Mr factor in human blood which confers serum resistance on gonococci: some properties and synergism with CMP-NANA.
Constantinidou C; Beadle D; Zhou XH; Parsons NJ; Sammons CC; Cole JA; Smith H
Microb Pathog; 1992 Jun; 12(6):421-32. PubMed ID: 1522797
[TBL] [Abstract][Full Text] [Related]
9. Modification by sialic acid of Neisseria gonorrhoeae lipooligosaccharide epitope expression in human urethral exudates: an immunoelectron microscopic analysis.
Apicella MA; Mandrell RE; Shero M; Wilson ME; Griffiss JM; Brooks GF; Lammel C; Breen JF; Rice PA
J Infect Dis; 1990 Aug; 162(2):506-12. PubMed ID: 1695655
[TBL] [Abstract][Full Text] [Related]
10. Sialylation of lipopolysaccharide by CMP-NANA in viable gonococci is enhanced by low Mr material released from blood cell extracts but not by some UDP sugars.
Parsons NJ; Constantinidou C; Cole JA; Smith H
Microb Pathog; 1994 Jun; 16(6):413-21. PubMed ID: 7830528
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of conversion of Neisseria gonorrhoeae to resistance to complement by cytidine 5'-monophospho-N-acetyl neuraminic acid.
Emond JP; Dublanchet A; Goldner M
Antonie Van Leeuwenhoek; 1995; 67(3):281-8. PubMed ID: 7778896
[TBL] [Abstract][Full Text] [Related]
12. Interaction of pathogenic Neisseria with host defenses. What happens in vivo?
Rest RF; Liu J; Talukdar R; Frangipane JV; Simon D
Ann N Y Acad Sci; 1994 Aug; 730():182-96. PubMed ID: 8080170
[TBL] [Abstract][Full Text] [Related]
13. Growth of Neisseria gonorrhoeae in CMP-N-acetylneuraminic acid inhibits nonopsonic (opacity-associated outer membrane protein-mediated) interactions with human neutrophils.
Rest RF; Frangipane JV
Infect Immun; 1992 Mar; 60(3):989-97. PubMed ID: 1541573
[TBL] [Abstract][Full Text] [Related]
14. The Lst Sialyltransferase of Neisseria gonorrhoeae Can Transfer Keto-Deoxyoctanoate as the Terminal Sugar of Lipooligosaccharide: a Glyco-Achilles Heel That Provides a New Strategy for Vaccines to Prevent Gonorrhea.
Jen FE; Ketterer MR; Semchenko EA; Day CJ; Seib KL; Apicella MA; Jennings MP
mBio; 2021 Mar; 12(2):. PubMed ID: 33758087
[TBL] [Abstract][Full Text] [Related]
15. Regulation of gonococcal sialyltransferase, lipooligosaccharide, and serum resistance by glucose, pyruvate, and lactate.
McGee DJ; Rest RF
Infect Immun; 1996 Nov; 64(11):4630-7. PubMed ID: 8890217
[TBL] [Abstract][Full Text] [Related]
16. Effect of exogenous sialylation of the lipooligosaccharide of Neisseria gonorrhoeae on opsonophagocytosis.
Kim JJ; Zhou D; Mandrell RE; Griffiss JM
Infect Immun; 1992 Oct; 60(10):4439-42. PubMed ID: 1398958
[TBL] [Abstract][Full Text] [Related]
17. Expression of sialyltransferase is not required for interaction of Neisseria gonorrhoeae with human epithelial cells and human neutrophils.
McGee DJ; Chen GC; Rest RF
Infect Immun; 1996 Oct; 64(10):4129-36. PubMed ID: 8926079
[TBL] [Abstract][Full Text] [Related]
18. Molecular mimicry as a factor in the pathogenesis of human neisserial infections: in vitro and in vivo modification of the lipooligosaccharide of Neisseria gonorrhoeae by N-acetylneuraminic acid.
Apicella MA; Mandrell RE
Pediatr Infect Dis J; 1989 Dec; 8(12):901-2. PubMed ID: 2483261
[No Abstract] [Full Text] [Related]
19. Neisseria gonorrhoeae LPS variation, serum resistance and its induction by cytidine 5'-monophospho-N-acetylneuraminic acid.
Demarco de Hormaeche R; van Crevel R; Hormaeche CE
Microb Pathog; 1991 Apr; 10(4):323-32. PubMed ID: 1716719
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic CMP-Nonulosonates against Multidrug-Resistant
Gulati S; Schoenhofen IC; Lindhout-Djukic T; Schur MJ; Landig CS; Saha S; Deng L; Lewis LA; Zheng B; Varki A; Ram S
J Immunol; 2020 Jun; 204(12):3283-3295. PubMed ID: 32434942
[No Abstract] [Full Text] [Related]
[Next] [New Search]
